Document is current
Any future updates will be listed below
-
Authors
Krammer, Florian http://orcid.org/0000-0003-4121-776X
- License Information
-
More Information
Article History
First Online: 8 July 2021
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to serological assays for SARS-CoV-2 and Newcastle disease virus–based vaccines against SARS-CoV-2 that list F.K. as co-inventor. Mount Sinai has ‘spun out’ a company, Kantaro, to market serological tests for SARS-CoV-2. F.K. has consulted for Merck and Pfizer (before 2020) and currently consults for Pfizer, Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2.
Free to read: This content has been made available to all.
